XML 55 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1

5) Stock-based Compensation: Schedule of stock inventive plan changes (Tables)

9 Months Ended

Sep. 30, 2018

AsOfJune302018

Schedule of stock inventive plan changes

		Number of Class A Shares		Weighted Average Exercise Price		Number of Class C Shares		Weighted Average Exercise Price
Outstanding at December 31, 2017		880,426		$      4.35		523,603		$      5.24
Granted		-				-
Exercised		(36,133)				-
Cancelled		(5,704)				-
Outstanding at September 30, 2018		838,589		$      4.48		523,603		$      5.24
As of September 30, 2018:
Options exercisable		805,902		$      4.46		505,227		$      5.26
As of September 30, 2018:
Available options for future grant		421,241				165,638
Weighted average contractual term of options
outstanding at September 30, 2018		6.05 years				2.69 years
Weighted average contractual term of options
exercisable at September 30, 2018		6.05 years				2.45 years
Aggregated intrinsic value of options
outstanding at September 30, 2018 (1)		$867,356				$267,943
Aggregated intrinsic value of options
exercisable at September 30, 2018 (1)		$862,157				$260,592
(1) The Company used a stock price of $5.20 as of September 30, 2018 to derive intrinsic value.

AsOfJune302017

Schedule of stock inventive plan changes

		Number of Class A Shares		Weighted Average Exercise Price		Number of Class C Shares		Weighted Average Exercise Price
Outstanding at December 31, 2016		741,973		$      4.33		556,298		$      4.61
Granted		-				-
Exercised		-				(103,402)
Cancelled		-				(24,227)
Outstanding at September 30, 2017		741,973		$      4.33		428,669		$      5.59
As of September 30, 2017:
Options exercisable		706,854		$      4.21		407,669		$      5.50
As of September 30, 2017:
Available options for future grant		525,682				227,750
Weighted average contractual term of options
outstanding at September 30, 2017		6.62 years				2.63 years
Weighted average contractual term of options
exercisable at September 30, 2017		6.50 years				2.55 years
Aggregated intrinsic value of options
outstanding at September 30, 2017 (1)		$941,567				$151,012
Aggregated intrinsic value of options
exercisable at September 30, 2017 (1)		$941,311				$151,012
(1) The Company used a stock price of $5.10 as of September 30, 2017 to derive intrinsic value.

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementScenarioAxis=fil_AsOfJune302018Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=fil_AsOfJune302017Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: